Lördag 7 Juni | 18:41:57 Europe / Stockholm

Kalender

Est. tid*
2025-08-28 19:10 Kvartalsrapport 2025-Q2
2025-06-02 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2025-05-29 - Årsstämma
2025-04-29 - Bokslutskommuniké 2024
2025-02-12 - Extra Bolagsstämma 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2024-05-15 - Årsstämma
2024-05-07 - Bokslutskommuniké 2023
2023-10-11 - Extra Bolagsstämma 2023
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2023-05-26 - Årsstämma
2023-04-28 - Bokslutskommuniké 2022
2022-09-29 - Kvartalsrapport 2022-Q2
2022-09-02 - Extra Bolagsstämma 2022
2022-05-19 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2022-05-18 - Årsstämma
2022-04-29 - Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriVård & Omsorg
Brain+ är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa. Brain+ har sitt huvudkontor i Köpenhamn.
2025-06-06 16:56:33

INVESTOR NEWS

 

Copenhagen, Denmark, 6 June 2025 – Brain+ A/S (Nasdaq First North: BRAINP)

Brain+ A/S (“Brain+” or the “Company”) is hosting a webinar on Tuesday, 10 June 2025 at 13:00 CEST / 12:00 UK time. Link to the webinar. The webinar will feature Antony Hall, former lead inspector for the UK Quality Care Commission (CQC) and newly joined Brain+ advisor. The webinar will spotlight how Cognitive Stimulation Therapy (CST), delivered through Brain+’ Ayla platform, can effectively support dementia care providers in meeting the CQC’s new quality statements and regulatory expectations.

Brain+ is inviting its shareholders, other investors and stakeholders to a live webinar, which will take place on Tuesday, 10 June 2025 at 13:00 CEST / 12:00 UK time.

The webinar will be focused on the following topics:

  • Antony Hall, Brain+ advisor and former lead inspector for the Care Quality Commission (CQC) in England, will share insights on how new research reinforces the importance and broader potential of Cognitive Stimulation Therapy (CST) in delivering meaningful, measurable care for people with dementia. Antony will also explain how Brain+’ flagship dementia care product, Ayla – your CST Assistant, can help care homes comply with the quality measures under CQC’s Single Assessment Framework.
  • CEO Devika Wood alongside SVP of Partnerships Fiona Costello, will give an update on the recent progress of UK commercial activities, including newly signed UK care home partnership agreements, and provide a status on the near-term sales outlook and the value of current customer leads across the two targeted dementia care market segments: UK private care and residential homes and public memory service units under the NHS.

 

Interested participants can sign up and ask questions in advance via the following link:

Brain+ webinar: How new CST evidence and UK dementia care quality focus underscore the relevance and potential of Ayla

The webinar can also be accessed via the event calendar page in the Investor section of Brain+’ website: Event Calendar - Brain+

A replay of the webinar will be available on Stokk.io via the same link and on the Brain+’ website following the event.

 

Contact Information

CEO, Devika Wood: + 44 7429 280366, devika@brain-plus.com

CFO, Hanne Vissing Leth: +45 53 88 99 02, hanne@brain-plus.com

 

Brain+ vision: Building the world’s first scalable dementia care platform to help people affected by dementia, live better lives.